These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19160785)

  • 1. [Studies on cyclodextrin inclusion complexes of Dragon's blood and its tablets preparation].
    Han BB; Pei HN; Sun HS; Ning QK; Ren Y
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2066-70. PubMed ID: 19160785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
    Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
    AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of coated tablets of glycyrrhetic acid-HP-beta-cyclodextrin tablets for colon-specific release].
    Cui QH; Cui JH; Zhang JJ
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2339-43. PubMed ID: 19157122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Solubilization on cryptotanshinone by hydroxypropyl-beta-cyclodextrin and preparation of their inclusion compound].
    Luo X; Xu YH; Chen B; Gu LQ; Huang M; Liu PQ
    Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1328-31. PubMed ID: 16323539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
    Moore E; Bergamo R; Casella R
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation process of rutacarpine-hydroxypropyl-beta-cyclodextrin inclusion complex].
    Yan CL; Zhang J; Hou Y; Xue GP; Wang S; Zhao QY
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):828-32. PubMed ID: 25204173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of alpha-hydrocycholic-beta-cyclodextrin inclusion compound].
    Bian YH; Zhang DY; Xiong QP
    Zhong Yao Cai; 2007 Nov; 30(11):1452-5. PubMed ID: 18323220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
    Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS
    J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S; Jain SK
    Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
    Rawat S; Jain SK
    Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the inclusions of xindonin A-beta-cyclodextrin and xindonin B-beta-cyclodextrin].
    Zhang Y; Xue H; Kou X; Wang G
    Zhong Yao Cai; 2001 Feb; 24(2):131-2. PubMed ID: 11402732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the improved effects of 2-hydroxypropyl-beta-cyclodextrin on solubility, dissolution rate, and intestinal absorptive profile of tanshinone IIA in rats.
    Wang L; Jiang X; Li C; Ren J
    Arch Pharm Res; 2007 Aug; 30(8):1020-6. PubMed ID: 17879757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.